Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.22 AUD | +1.16% | -3.78% | -9.60% |
Apr. 24 | Atlas Arteria's Average Traffic Inches Down in Q1 | MT |
Apr. 12 | Atlas Arteria's 66.7%-Owned Chicago Skyway Prices $205 Million US Private Placement of Notes | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 93% by 2026.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- This company will be of major interest to investors in search of a high dividend stock.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- Based on current prices, the company has particularly high valuation levels.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Highways & Rail Tracks
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-9.60% | 4.88B | B- | ||
-7.88% | 25.09B | A- | ||
+0.22% | 20.21B | - | B | |
+17.30% | 10.79B | C+ | ||
+10.26% | 7.27B | B- | ||
+9.97% | 6.98B | - | ||
+5.41% | 6.49B | - | B | |
+33.00% | 6.17B | B- | ||
-11.92% | 4.91B | B | ||
+0.58% | 3.94B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ALX Stock
- Ratings Atlas Arteria Limited